PRAX
Praxis Precision Medicines Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
PRAX: Steve Cohen bought shares, Piper Sandler gave it $18 price target
PRAX: Steve Cohen bought shares, Piper Sandler gave it $18 price target
Mentions
I know this is not penny stocks, but this $PRAX went this morning from $49 to $200 . Imagine just buying one share would make you $150 . We are in wrong business 😂
Who ever heard of PRAX, could have retired all WSB
Which of you regards had any PRAX options? give me 10 bucks for some wendys thanks
so I might be a little too late for PRAX
PRAX, a $3.6B company that is up by 200% today
Anyone know why PRAX is up 147%?
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-announces-positive-topline-results-from-jtbxnj5gm2ot.html
I am dumbass, I saw PRAX news just when announced and checked the stock it was still 59.. and after 5 min it was 150. I think I was the first one who saw news.
What is going on with PRAX
Upexi, Inc., a brand owner, engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; craft cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and cash management of assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Tampa, Florida. 🤔😂
I have been doing this for quite some time. I never use more than 66% of my capital. I target companies I like. I only trade when the return justifies the risk, 3%, 21-45DTE and 10-15% otm. I rarely use delta to make a decision, but more often than not it is under .3 delta. I do get assigned sometimes, but turn them into green with cc. I hardly ever roll out, but I do close them early if I do not like the price action and it is green. I look for historical volatility vs current volatility and try to plan an exit strategy if the volatility collapses, which mostly happens after earnings passed and you ended up assigned. It happened to me with PRAX and GME
Sad, really, that you think buying penny stocks and garbage options are an advantage a day-trader would have over hedge funds. In 2023 Point72 Asset Management bought a basket of penny stocks - DNN, PRAX, CRNX, INSP, that's Steve Cohen's fund. Not that it matters at this point, but neither is true, hedge funds can buy both penny stocks and garbage options, they almost never do for the obvious reason.
Hey, love this breakdown — thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline — are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved — partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** – Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** – Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** – A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
Hey, love this breakdown — thanks for bringing $VTGN back on the radar! That fasedienol angle is interesting, especially the part about non-sedative, fast-acting treatment for Social Anxiety Disorder. A couple quick questions though: * Did they share any new data on efficacy or just reiterate prior findings at the ADAA conference? * Do you know where they are in the FDA timeline — are we expecting Phase 3 readouts soon or still in mid-stage? * Any word on how they plan to commercialize fasedienol if approved — partner, go solo, or license it out? Also, out of curiosity, how do you think $VTGN stacks up right now against some other CNS/mood-focused names like: * **$MNMD (MindMed)** – Also targeting anxiety but with a psychedelic pipeline (MM-120 for GAD). Higher risk, but also drawing attention for novel mechanisms. * **$AXSM (Axsome Therapeutics)** – Their AXS-05 (approved for depression) gives them a revenue-generating foothold while they explore more indications. Stronger fundamentals but less upside room maybe? * **$PRAX (Praxis Precision Medicines)** – A bit broader in CNS but working on fast-acting neuropsychiatric therapies. Similar to $VTGN in trying to fill unmet needs but still in development phase for most.
PRAX - pharma - BUY JSPR - pharma - BUY ROOT - AI Insure-tech - BUY IMPP - oil tankers - BUY CISS - oil tankers - BUY CDE - gold/silver - BUY PRAX Buy. How will this company make money? $3B epilepsy treatment market. Clinical trial results "100% of patients reached a complete response. This means all signs of the disease disappeared completely." JSPR Buy. How will this company make money? Treatments for Cancer and a cure for AIDS. Lead drug is critical for stem cell transplants (SCT) and Stem Cell Therapies. ROOT. Buy. How will this company make money? Leader in automated insurance. Scaling up much faster than competitors. IMPP, CISS. Buy Oil tankers critical need, Revenue/Net Income >>>>> Market Cap, No debt CDE. Gold/Silver mining company. Gold and Silver are rising rapidly in price, CDE is like a leveraged bet on Gold/Silver continuing to rise.
Do you have any thoughts on PRAX. I bought in the 20’s and have been adding to my position. This seems very spec.
Praxis ($PRAX) best bet you can make in 2024!
Tomorrow I'll buy more praxis precison medicines stocks ( $PRAX). Interesting company, small market cap atm.
$PRAX, interesting bet. Low market cap compared to relative big pharma deal they made with China.
$PRAX doing very well today!
I strongly believe gene therapy, as well as AI and computer-aided drug discovery companies, will revolutionize medicine in the near future, starting this decade. That's why, this year, I added CRSP, DNA, NTLA, ABSI, PRAX, BEAM, and SDGR to my portfolio.
Gene and AI focused biotech - CRSP, NTLA, definitely DNA, BEAM, PRAX New computing - NVTS, RGTI
PRAX -- Following its breakthrough past the 1.24 mark, it rallied 15%. It was in the cards.
Not in PRAX but I wish I was last week.
Loading up on PRAX https://finance.yahoo.com/news/billionaire-steve-cohen-loads-2-140458179.html
PRAX -- From a technical standpoint, keep an eye on the $1.24 mark. A breakthrough above this level has the potential to trigger a substantial rally. Piper Sandler gave it $18 price target [https://finance.yahoo.com/news/billionaire-steve-cohen-loads-2-140458179.html](https://finance.yahoo.com/news/billionaire-steve-cohen-loads-2-140458179.html)
Guys, check out PRAX -- Steve Cohen bought shares, Piper Sandler gave it 1,500% upside [https://finance.yahoo.com/news/billionaire-steve-cohen-loads-2-140458179.html](https://finance.yahoo.com/news/billionaire-steve-cohen-loads-2-140458179.html)
Almost shorted @ 1.38. This has no business being over a dollar. This market is hysterical. I'm watching PRAX for a breakout of lows. Insiders continually buying and with current volume it would take shorts more then a week to cover. Same with PRPL. Both charts look like a$$ if you know what I mean.
SEAC ER smash, potential gapper. ARBB one of few IPOs with sound fundamentals, freshly listed less than 1 million intraday volume. Shorted out the gate. PRAX beaten down to a pulp from SVB debacle, started curling for a reversal with insider buys. Gains will come and go quick, do not chase. NOTE potential squeeze but I am accumulating long. AI with government contracts, excellent guidance and projected to be cash flow positive by eoy.
Or a short covering to have capital to short it again on the next little pop. More than likely sub $2 tomorrow. It will be a good play... you are early. Same with PRAX... got in too early @ .95 but once it finds the actually floor a 50-100% pop is eminent.
Keep an eye on $NOTE ER tomorrow and $SOUN. Some big insider buys reported for $PRAX and $AKAN on watch for a post split run. $NOTE $SOUN $AKAN all AI stocks and $PRAX is bio. $ZFOX also appears to be making a reversal (cyber security)
Markets will continue to fall. Holding my biotechs TENX at PRAX.
Biotechs TENX and PRAX next.
Markets are going to keep going down, but biotechs will climb. PRAX and TENX
It can go above 100%. Here's an example: https://www.barchart.com/options/highest-implied-volatility At the time I'm typing this, the 2.50 put on PRAX has an IV of 504%. I don't think IV can be 0. I think it's a non-zero positive number.
Finally the market is picking back up. A couple pharma stocks I’ve been holding onto for a year have had some good movement like PRAX
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: PRAX. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
HCAT/PRAX both the lowest they’ve ever been with hints of a mean reversal. ❤️